Coverage
-
September 29, 2017
A Pennsylvania federal judge said Friday that a pair of consultants could not rely on racketeering laws to hold GlaxoSmithKline LLC liable for allegedly landing them in Chinese prison after duping them into investigating an innocent whistleblower.
1 other articles on this case.
View all »